| Name | doxapram hydrochloride monohydrate |
|---|---|
| Synonyms |
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
Doxapram hydrochloride monohydrate Dopram Doxapram hydrochloride hydrate, 10 mM in DMSO DOTHIINHYDROCHLORIDE,ANHYDROUS 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochloride, hydrate(1:1:1) Doxapram hydrochloride monohydrate //BP doxapramhydrochloridehydrate 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinonmonohydrochloride Respiram hydrochloride hydrate stimulexin 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinonehydrochloridehydr DOPRAM HYDROCHLORIDE HYDRATE;STIMULEX HYDROCHLORIDE HYDRATE;RESPIRAM HYDROCHLORIDE HYDRATE DoxapraM Hydrochoride Monohydrate Stimulexin 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate 2-Pyrrolidinone, 1-ethyl-(4-morpholinyl)ethyl-3,3-diphenyl-, monohydrochloride, monohydrate AHR 619 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate Doxapram Hydrochloride Doxapram hydrochloride (AHR-619) (4S)-1-ethyl-4-[2-(Morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one Stimulex hydrochloride hydrate DoxapraM HCL API (4RS)-1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3- diphenylpyrrolidin-2-one hydrochloride 1-Ethyl-4-[2-(4-Morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, Monohydrochloride, Monohydrate (9CI) DOXAPRAM HCL Doxapram HCL 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate(8CI) DoxapraM Hydrochloride Doxapram Hydrochloride hydrate Dopram (TN) 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one,hydrate,hydrochloride 1-Ethyl-4-(2-Morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloridehydrate 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate Dopram hydrochloride hydrate UNII:P5RU6UOQ5Y Doxapram hydrochloride monohyd Doxapram Hydrochoride Doxapram monohydrochloride monohydrate 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochloride Doxapram Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base) 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidone hydrate hydrochloride 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-dhenyl-2-pyrrolidinone hydrochloride monohydrate 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride, hydrate (1:1:1) 1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate Doxapram hydrochloride CRS oxapramhydrochloridemonohydrate Doxapram HCl H2O Doxapram Hydrochloride Doxapram Hydrochloride 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochloride |
| Description | Doxapram hydrochloride hydrate inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.Target: Potassium ChannelDoxapram is a respiratory stimulant. Doxapram (15-150 microM) also evoked 3H overflow in a concentration dependent manner, and doxapram-evoked release was inhibited by the Ca2+ channel blocker nifedipine (5 microM). Analysis of released tritiated compounds suggested that doxapram preferentially stimulated the release of dopamine. Our results indicate that the mechanism of action of doxapram shares similarities with that of hypoxia in the carotid body [1]. Doxapram (1-100 microM) caused rapid, reversible and dose-dependent inhibitions of K+ currents recorded in type I cells (IC50 approximately 13 microM). doxapram was also seen to directly inhibit Ca(2+)-independent K+ currents. Doxapram was a more potent inhibitor of the Ca(2+)-activated K+ currents recorded under control conditions. Doxapram (10 microM) was without effect on L-type Ca2+ channel currents recorded under conditions where K+ channel activity was minimized and was also without significant effect on K+ currents recorded in the neuronal cell line NG-108 15, suggesting a selective effect on carotid body type I cells. The effects of doxapram on type I cells show similarities to those of the physiological stimuli of the carotid body, suggesting that doxapram may share a similar mechanism of action in stimulating the intact organ [2]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 217-219° |
|---|---|
| Molecular Formula | C24H33ClN2O3 |
| Molecular Weight | 432.983 |
| Exact Mass | 432.217957 |
| PSA | 42.01000 |
| LogP | 3.78680 |
| Water Solubility | Soluble in water, in alcohol and in methylene chloride. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | Missing Phrase - N15.00950417 |
| RIDADR | UN 2811 6.1 / PGIII |